Personal profile
Research Interests
Bio-inorganic Chemistry, Spectroscopy, Macrocyclic Chemistry
Education/Academic qualification
PhD
Fingerprint
Dive into the research topics where Bernadette Creaven is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Triple shot: method development & utilisation of a hyphenated system for the analysis of coffee
Paterek, R., Geoghegan, S., Creaven, B. S. & Power, A. C., 2026, (Accepted/In press) In: Journal of the Science of Food and Agriculture.Research output: Contribution to journal › Article › peer-review
-
Biofilm Eradication Using Water-Soluble Silver(I) Coumarin Complexes
Mooney, E., Cooke, G., Caraher, E., Kelleher, F. & Creaven, B. S., 2025, (Accepted/In press) In: ChemBioChem.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Retraction notice to “An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex” (Chem. Biol. Interact., (2007), 168, (143–158), 10.1016/j.cbi.2007.04.003)
Thati, B., Noble, A., Creaven, B. S., Walsh, M., Kavanagh, K. & Egan, D. A., 1 Dec 2025, In: Chemico-Biological Interactions. 422, 111804.Research output: Contribution to journal › Comment/debate
-
Retraction notice to “Apoptotic cell death: A possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa) (phen)2] (phen = phenanthroline, 4-Mecdoa = 4-methylcoumarin-6, 7-dioxactetate), in human malignant cancer cells” [Eur. J. Pharmacol. 569 (2007) 16–28, (S0014299907005432), (10.1016/j.ejphar.2007.04.064)]
Thati, B., Noble, A., Creaven, B. S., Walsh, M., Kavanagh, K. & Egan, D. A., 15 Oct 2025, In: European Journal of Pharmacology. 1005, 178059.Research output: Contribution to journal › Comment/debate
-
Retraction notice to “Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells” [Eur. J. Pharmacol. 602 (2009) 203–214, (S0014299908011485), (10.1016/j.ejphar.2008.11.020)]
Thati, B., Noble, A., Creaven, B. S., Walsh, M., McCann, M., Devereux, M., Kavanagh, K. & Egan, D. A., 15 Oct 2025, In: European Journal of Pharmacology. 1005, 178044.Research output: Contribution to journal › Comment/debate
Open Access